L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 54,300
-6,900 (-11.27%)
Sep 19, 2025, 3:30 PM KST
L&C BIO Co.,LTD Market Cap
L&C BIO Co.,LTD has a market cap or net worth of 1.34 trillion as of September 19, 2025. Its market cap has increased by 208.85% in one year.
Market Cap
1.34T
Enterprise Value
1.39T
Revenue
75.98B
Ranking
n/a
PE Ratio
10.89
Stock Price
54,300.00
Market Cap Chart
Since November 1, 2018, L&C BIO Co.,LTD's market cap has increased from 194.97B to 1.34T, an increase of 585.66%. That is a compound annual growth rate of 32.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 1,336.80B | 144.52% |
| Dec 30, 2024 | 546.71B | -16.90% |
| Dec 28, 2023 | 657.86B | 25.54% |
| Dec 29, 2022 | 524.02B | -36.89% |
| Dec 30, 2021 | 830.27B | 10.00% |
| Dec 30, 2020 | 754.76B | 300.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.24T |
| Celltrion | 37.12T |
| ALTEOGEN | 25.25T |
| Yuhan | 8,752.85B |
| SK Biopharmaceuticals | 8,450.00B |
| Peptron | 6,750.37B |
| PharmaResearch | 6,202.62B |
| ABL Bio | 5,910.48B |